1-9 of 9
James Olen Armitage, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I/II Trial of Lenalidomide and Ofatumumab for the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

Avyakta Kallam, MBBS, Jane Meza, PhD, Philip Bierman, MD, Matthew A. Lunning, DO, R. Gregory Bociek, MD, James Olen Armitage, MD, Julie M Vose, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4039.
https://doi.org/10.1182/blood.V130.Suppl_1.4039.4039
Published: 2017
Journal Articles

Overall Survival (OS) of Acute Lymphoblastic Leukemia (ALL) Is Better When Initial Therapy Is Administered in Academic Hospitals (AH) Versus Non-Academic Hospitals (NAH): A Retrospective Analysis of the National Cancer Data Base (NCDB)

Roberto A. Ferro, MD, Valerie Shostrom, MS, Julie M. Vose, MD, Krishna Gundabolu, MD, Smith Giri, MBBS, KM Monirul Islam, MDPhD, Lori J. Maness, MD, James Olen Armitage, MD, Vijaya R. Bhatt, MD
Journal: Blood
Blood (2015) 126 (23): 268.
https://doi.org/10.1182/blood.V126.23.268.268
Published: 2015
Journal Articles

Trend Analysis of Clinical Outcomes in Hodgkin Lymphoma over the Last Three Decades: Report from the Nebraska Lymphoma Study Group

Kailash Mosalpuria, MD MPH, Fausto R Loberiza, MD MS, R. Gregory Bociek, MD, Matthew A. Lunning, DO, Apar Kishor Ganti, MD, James Olen Armitage, MD, Julie M. Vose, MD, Philip Bierman, MD
Journal: Blood
Blood (2014) 124 (21): 1284.
https://doi.org/10.1182/blood.V124.21.1284.1284
Published: 2014
Journal Articles

Disparity In Clinical Outcomes Of Elderly Patients With Non-Hodgkin Lymphoma After Autologous Hematopoietic Stem Cell Transplantation According To Area Of Residence

Andrew C. Cannon, B.S., James Olen Armitage, MD, Philip Bierman, MD, R. Gregory Bociek, MD, Julie M. Vose, MD, Fausto R. Loberiza, Jr., MD, MS
Journal: Blood
Blood (2013) 122 (21): 1744.
https://doi.org/10.1182/blood.V122.21.1744.1744
Published: 2013
Journal Articles

Survival Disparities in Patients with Lymphoma According to Place of Residence and Treatment Provider: A Population-Based Study

Fausto R Loberiza, Jr., MD, MS, Anthony J Cannon, Dennis D Weisenburger, MD, Julie M. Vose, MD, Matt J. Moehr, MS, Martin A. Bast, Philip Bierman, MD, R. Gregory Bociek, MD, James Olen Armitage, MD
Journal: Blood
Blood (2008) 112 (11): 874.
https://doi.org/10.1182/blood.V112.11.874.874
Published: 2008
Journal Articles

Outcome of Limited-Stage Peripheral T-Cell Lymphoma: Results from the Nebraska Lymphoma Study Group.

Philip Bierman, MD, Julie M. Vose, MD, R. Gregory Bociek, MD, Fausto Loberiza, MD, Martin Bast, BS, Dennis D. Weisenburger, MD, James Olen Armitage, MD
Journal: Blood
Blood (2007) 110 (11): 3451.
https://doi.org/10.1182/blood.V110.11.3451.3451
Published: 2007
Journal Articles

Clinical and Pathological Differences between Nasal and Nasal-Type NK/T Cell Lymphomas: A Summary of 136 Cases from the International T Cell Lymphoma (ITCL) Project.

Wing Au, MD, Tanin Intragumtornchai, MD, Shigeo Nakamura, MD, James Olen Armitage, MD, Raymond Liang, MD
Journal: Blood
Blood (2006) 108 (11): 292.
https://doi.org/10.1182/blood.V108.11.292.292
Published: 2006
Journal Articles

High-Dose Chemotherapy Followed by Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Lymphocyte Predominant Hodgkin’s Disease.

Philip Bierman, MD, Hina Naushad, MD, Fausto Loberiza, MD, R. Gregory Bociek, MD, Julie M. Vose, MD, James Olen Armitage, MD, Patricia Aoun, MD
Journal: Blood
Blood (2006) 108 (11): 3061.
https://doi.org/10.1182/blood.V108.11.3061.3061
Published: 2006
Journal Articles

Significance of c-myc Rearrangements in Diffuse Large B-Cell Lymphoma.

Philip Bierman, MD, Fausto Loberiza, MD, Bhavana Dave, PhD, Warren Sanger, PhD, R. Gregory Bociek, MD, Martin Bast, BS, Julie M. Vose, MD, James Olen Armitage, MD, Dennis Weisenburger, MD
Journal: Blood
Blood (2006) 108 (11): 2030.
https://doi.org/10.1182/blood.V108.11.2030.2030
Published: 2006